Company
Headquarters: Tokyo, Japan
Employees: 3,291
CEO: Mr. Kotaro Fukuda
¥194.13 Billion
JPY as of Jan. 1, 2026
US$1.24 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $216.15 B |
| Boston Scientific Corporation | $140.40 B |
| Stryker | $133.15 B |
| Medtronic | $123.20 B |
| Edwards Lifesciences Corporation | $50.10 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Fukuda Denshi Co., Ltd. develops, manufactures, and sells medical electronic equipment worldwide. It provides resting electrocardiograph products; data management software; stress test products; Holter products and software; and patient monitoring systems, including central and bedside monitors, digital transmitters, and central viewer workstations. The company also offers defibrillator monitors; and ultrasound systems, as well as vascular screening systems. Fukuda Denshi Co., Ltd. was founded in 1939 and is based in Tokyo, Japan.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | ¥139.50 B |
| EBITDA | ¥36.97 B |
| Gross Profit TTM | ¥75.51 B |
| Profit Margin | 13.25% |
| Operating Margin | 18.83% |
| Quarterly Revenue Growth | 1.30% |
Fukuda Denshi Co. Ltd has the following listings and related stock indices.
Stock: JPX: 6960 wb_incandescent